IP Library Granted Patent US 9,220,741
Granted Patent B2
US 9,220,741 · App. 13/221,141 · Granted Dec 29, 2015

Weight loss formulation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,220,741
App. No.
13/221,141
Granted
Dec 29, 2015
Kind
B2
Abstract

A method of enhancing weight loss involves administering to an overweight human a weight loss product that includes a mixture of Alchemilla vulgaris, Olea europaea, Cuminum cyminum , and Mentha longiflora (in the weight proportion 12:10:5:4), to which is added at least one herbal ingredient such as Malpighia glabra . As additional ingredients at least one of Conjugated linoleic acid and caffeine can be provided, with the caffeine in the form of caffeine anhydrous, Coffea Arabica, Coffea canephora, Camellia sinensis, Ilex paraguariensis, Guarana, Theobroma cacao , and kola nut. In one preferred embodiment the method involves administering, optionally in tablet form, a composition consisting essentially of the mixture of Alchemilla vulgaris, Olea europaea, Cuminum cyminum , and Mentha longiflora ; caffeine anhydrous; Vitamin C; Lyceum barbarum; Malpighia glabra ; Blueberry; Punica granatum ; Bilberry; and one or more excipients. Other ingredients may be used as well in accordance with specific disclosed formulations.

Claims (53)

1. A method of enhancing weight loss in an overweight human individual comprising administering to the individual an effective amount of a composition consisting essentially of a mixture of Alchemilla vulgaris, Olea europaea, Cuminum cyminum , and Mentha longiflora ; caffeine anhydrous; Vitamin C; Lyceum barbarum; Malpighia glabra ; Blueberry; Punica granatum ; Bilberry; and one or more excipients.

2. A method of enhancing weight loss as in claim 1 , wherein the ingredients of the composition are present in the following respective forms and weight percentages:

% (wt.)

Ingredient

of total

(i) the mixture of Alchemilla vulgaris ) (leaf); Olea

12.142498

europaea ) (leaf); Cuminum cyminum (seed), and Mentha

longiflora (leaf)

(ii) caffeine anhydrous

7.213365

(iii) Vitamin C (ascorbic acid) - granular

0.295267

(iv) Lyceum barbarum - fruit

0.040074

(v) Melpighia glabra (concentrate 4-5:1) - fruit

0.040074

(vi) Blueberry powder ( Vaccinium corymbosum ) - fruit

0.040074

(vii) Punica granatum - fruit and seed

0.040074

(viii) Bilberry extract 4:1 ( Vaccinium myrtillus ) - fruit

0.040074

(ix) One or more excipients

Remainder.

3. A method of enhancing weight loss as in claim 2 , wherein the mixture ingredients are present in the mixture in the following proportions:

Alchemilla vulgaris— 12 parts by weight;

Olea europaea —10 parts by weight;

Cuminum cyminum —5 parts by weight; and

Mentha longiflora —4 parts by weight.

4. A method of enhancing weight loss as in claim 3 , wherein the composition is provided in tablet form, each tablet including the following amounts by weight of the respective ingredients:

Ingredient

Weight (g)

(i) the mixture of Alchemilla vulgaris ) (leaf); Olea

0.303000

europaea ) (leaf); Cuminum cyminum (seed), and Mentha

longiflora (leaf)

(ii) caffeine anhydrous

0.180000

(iii) Vitamin C (ascorbic acid) - granular

0.007368

(iv) Lyceum barbarum - fruit

0.000100

(v) Melpighia glabra (concentrate 4-5:1) - fruit

0.000100

(vi) Blueberry powder ( Vaccinium corymbosum ) - fruit

0.000100

(vii) Pomegranate powder ( Punica granatum ) - fruit and

0.000100

seed

(viii) Bilberry extract 4:1 ( Vaccinium myrtillus ) - fruit

 0.000100.

5. A method of enhancing weight loss as in claim 4 , wherein the method comprises administering two tablets to the individual three times a day.

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded May 29, 2026
From: ROYAL BANK OF CANADA
To: NORTHERN INNOVATIONS HOLDING CORP.
Reel/Frame 075647/0267 →
SECURITY AGREEMENT Recorded May 28, 2026
From: LOVATE HEALTH SCIENCES INTERNATIONAL INC.; NORTHERN INNOVATIONS HOLDING CORP.; LOVATE HEATH SCIENCES U.S.A. INC.
To: FGI WORLDWIDE LLC
Reel/Frame 075641/0893 →
MERGER AND CHANGE OF NAME Recorded Sep 30, 2024
From: ROYAL BANK OF CANADA; HSBC TRUST COMPANY (CANADA); HSBC MORTGAGE CORPORATION (CANADA); HSBC FINANCE MORTGAGES INC.; HSBC BANK CANADA + 4 OTHERS NOTED ABOVE IN 'CONVEYING PARTY DATA'
To: ROYAL BANK OF CANADA/BANQUE ROYALE DU CANADA
Reel/Frame 069072/0683 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SERIAL NUMBER OF PATENT NUMBER 7,645,812 TO 7,465,812 PREVIOUSLY RECORDED AT REEL: 059662 FRAME: 0958. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Apr 26, 2022
From: NORTHERN INNOVATIONS HOLDING CORP.
To: HSBC BANK CANADA
Reel/Frame 059793/0777 →
SECURITY INTEREST Recorded Apr 21, 2022
From: NORTHERN INNOVATIONS HOLDING CORP.
To: HSBC BANK CANADA
Reel/Frame 059662/0958 →
CHANGE OF NAME Recorded Jun 27, 2016
From: 2462096 ONTARIO LIMITED
To: NORTHERN INNOVATIONS HOLDING CORP.
Reel/Frame 039172/0827 →
CHANGE OF NAME Recorded Jun 27, 2016
From: 2508304 ONTARIO LIMITED
To: NORTHERN INNOVATIONS HOLDING CORP.
Reel/Frame 039173/0329 →
MERGER Recorded Jun 27, 2016
From: NORTHERN INNOVATIONS HOLDING CORP.
To: OLD NORTHERN INNOVATIONS CORP.
Reel/Frame 039018/0928 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2016
From: OLD NORTHERN INNOVATIONS CORP.
To: 2462096 ONTARIO LIMITED
Reel/Frame 039013/0732 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2016
From: OLD NORTHERN INNOVATIONS CORP.
To: 2508304 ONTARIO LIMITED
Reel/Frame 039019/0596 →
MERGER Recorded Jun 27, 2016
From: NORTHERN INNOVATIONS AND FORMULATIONS CORP.
To: NORTHERN INNOVATIONS HOLDING CORP.
Reel/Frame 039171/0167 →
CHANGE OF NAME Recorded Jun 27, 2016
From: NORTHERN INNOVATIONS HOLDING CORP.
To: OLD NORTHERN INNOVATIONS CORP.
Reel/Frame 039171/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2011
From: AKRONG, JAMES; APONG, PHIL; BASHIR, RAZA; WISSENT, CRAIG; SHIRAZI, SHAWN
To: NORTHERN INNOVATIONS AND FORMULATIONS CORP.
Reel/Frame 026828/0958 →